Pirfenidone blocks the in vitro and in vivo effects of staphylococcal enterotoxin B

被引:42
作者
Hale, ML
Margolin, SB
Krakauer, T
Roy, CJ
Stiles, BG
机构
[1] USA, Med Res Inst Infect Dis, Div Toxicol, Ft Detrick, MD 21702 USA
[2] Marnac Inc, Dallas, TX 75225 USA
关键词
D O I
10.1128/IAI.70.6.2989-2994.2002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pirfenidone [5-methyl-1-phenyl-2-(1H)-pyridone] down-regulates expression of cytokines and other mediators involved in the onset and development of pulmonary fibrosis. Pirfenidone also inhibits production of tumor necrosis factor alpha (TNF-alpha) from macrophages incubated with endotoxin and protects mice against endotoxin shock. Pirfenidone's ability to reduce cytokine expression in these disorders led us to investigate the drug's effect on another cytokine anomaly, superantigen-induced shock. BALB/c mice were exposed to staphylococcal enterotoxin B (SEB) either systemically or by aerosol and subsequently potentiated with a sublethal dose of lipopolysaccharide. In these experiments, pirfenidone given 2 to 4.25 h after SEB resulted in 80 to 100% survival versus only 0 to 10% survival among untreated control animals. Relative to serum cytokine levels from controls given toxin but no drug, there was a 35 to 80% decrease in TNF-alpha, interleukin 1, and other proinflammatory cytokines. In vitro experiments with human peripheral blood lymphocytes revealed that pirfenidone reduced SEB-induced cytokine levels 50 to 80% and inhibited 95% of SEB-induced T-cell proliferation. Overall, these studies demonstrated the potential utility of pirfenidone as a therapeutic against septic shock and the biological effects of SEB.
引用
收藏
页码:2989 / 2994
页数:6
相关论文
共 49 条
[21]  
JOHNSON HM, 1991, P SOC EXP BIOL MED, V198, P765, DOI 10.3181/00379727-198-43321A
[22]   Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts [J].
Kaneko, M ;
Inoue, H ;
Nakazawa, R ;
Azuma, N ;
Suzuki, M ;
Yamauchi, S ;
Margolin, SB ;
Tsubota, K ;
Saito, I .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1998, 113 (01) :72-76
[23]   MUTATIONS DEFINING FUNCTIONAL REGIONS OF THE SUPERANTIGEN STAPHYLOCOCCAL ENTEROTOXIN-B [J].
KAPPLER, JW ;
HERMAN, A ;
CLEMENTS, J ;
MARRACK, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :387-396
[24]  
Kasai T, 1997, RES COMMUN MOL PATH, V98, P34
[25]   Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release [J].
Krakauer, T ;
Stiles, BG .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1999, 6 (04) :594-598
[26]   Immune response to staphylococcal superantigens [J].
Krakauer, T .
IMMUNOLOGIC RESEARCH, 1999, 20 (02) :163-173
[27]   Protective effects of niacinamide in staphylococcal enterotoxin-B-induced toxicity [J].
LeClaire, RD ;
Kell, W ;
Bavari, S ;
Smith, TJ ;
Hunt, RE .
TOXICOLOGY, 1996, 107 (01) :69-81
[28]   Potentiation of inhaled staphylococcal enterotoxin B-induced toxicity by lipopolysaccharide in mice [J].
LeClaire, RD ;
Hunt, RE ;
Bavari, S ;
Estep, JE ;
Nelson, GO ;
Wilhelmsen, CL .
TOXICOLOGIC PATHOLOGY, 1996, 24 (05) :619-626
[29]   The TNF and TNF receptor superfamilies: Integrating mammalian biology [J].
Locksley, RM ;
Killeen, N ;
Lenardo, MJ .
CELL, 2001, 104 (04) :487-501
[30]   THE STAPHYLOCOCCAL ENTEROTOXINS AND THEIR RELATIVES [J].
MARRACK, P ;
KAPPLER, J .
SCIENCE, 1990, 248 (4956) :705-711